Researchers: Rolf Johansson, Mona-Landin Olsson (Lund University Hospital), Per Hagander, Fredrik Ståhl
This project is co-funded by the EU through the ICT programme under FP7 (Ref. ICT-216592)
European Commission—ICT for Health: http://europa.eu.int/information_society/activities/health/index_en.htmThe DIAdvisor™ is a large-scale integrating project (IP) aiming at the development of a prediction based tool which uses past and easily available information to optimise the therapy of type I and developed type II diabetes. The DIAdvisor™ is not dependent on specific sensor technologies and can be adapted to technologies like standard strip sensing, minimally-invasive continuous glucose sensors and emerging non-invasive methods.
For safety reason, the DIAdvisor™ system will be able to self-assess the confidence of its proposed decisions. For safety reasons as well as for the sake of therapy improvements, the system connects and provides information and trends to the Health Care Provider.
Glucose prediction is difficult and requires advanced science within the fields of physiological modelling, identification theory, control theory, medical device technology, risk management theory, sensor science and user understanding. It can be achieved only by a well balanced group of eminent experts, including academics, clinicians, user representatives and leading companies.
The expected impact of DIAdvisor™ will be improved diabetes control and quality of life in large populations of insulin treated patients, leading to fewer diabetic complications and lower Health Care costs. Moreover, the project will constitute a valuable opportunity for European companies to build up a special know-how leading to products that profoundly and positively have an impact on the lives of millions of people with other indications than diabetes.
| Organisation | Web site | Role |
|---|---|---|
| Novo Nordisk A/S, Bagsværd, Denmark | www.novonordisk.com | Coordinator |
| Johannes Kepler University, Linz, Austria | www.jku.at | Control & advisory algorithms |
| Lunds University, Lund, Sweden | www.lu.se | Data based models |
| University of Padova, Padova, Italy | www.unipd.it | Physiological models and clinical trials |
| Centre Hospitalier Universitaire de Montpellier, Montpellier, France | www.chu-montpellier.fr | Clinical trials |
| Toumaz Technology Ltd, Abingdon, UK | www.toumaz.com | Device integration |
| Sensor Technology and Devices Ltd, Belfast, UK | www.stnd.com | Vital sign sensors |
| Ondalys, Montpellier, France | www.ondalys.fr | Non invasive glucose measurement |
| RomSoft, Iasi, Romania | www.rms.ro | Software |
| Institute for Clinical and Experimental Medicine , Prague, Czech Republic | www.ikem.cz | Clinical trials |
| RICAM, Linz, Austria | www.ricam.oeaw.ac.at | Mathematics |
| Ramboll, Virum, Denmark | www.ramboll.com | Risk management |
| Federation Internationale du Diabete Region Europe, Brussels, Belgium | www.idf-europe.org | Validation and Dissemination |
Jens Ulrik Poulsen
Novo Nordisk A/S
DK-3400 Hilleroed
Denmark
Phone: +45 4443 9692
http://www.novonordisk.com/
Back
to Research
Homepage
of Automatic Control